British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine

Russell, Mark D; Dey, Mrinalini; Flint, Julia; Davie, Philippa; Allen, Alexander; Crossley, Amy; Frishman, Margreta; Gayed, Mary; Hodson, Kenneth; Khamashta, Munther; Moore, Louise; Panchal, Sonia; Piper, Madeleine; Reid, Clare; Saxby, Katherine; Schreiber, Karen; Senvar, Naz; Tosounidou, Sofia; van de Venne, Maud; Warburton, Louise; Williams, David; Yee, Chee-Seng; Gordon, Caroline; Giles, Ian

Affiliation

King's College London; University of Liverpool; Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust; Sandwell and West Birmingham NHS Trust; et al.

Publication date

2024-02-01

Subject

Rheumatology

Metadata

Show full item record

Abstract

No abstract available

Citation

Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I. British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine. Rheumatology (Oxford). 2024 Feb 1;63(2):e37-e38. doi: 10.1093/rheumatology/kead384

Type

Article